These findings, together with data suggestive of nNOS dysfunction in cerebrovascular disease states such as ischaemia and migraine (as well as neurodegenerative conditions) highlight cerebral nNOS signalling as a potential therapeutic target for further investigations in the future. The gene discussed is NOS1; the disease is migraine disorder.